Abstract
Aims To evaluate the factors that predict reulceration beneath the hallux in people with a history of diabetic foot ulceration. Methods A prospective study conducted between January 2012 and December 2014 was performed in a diabetic foot unit to assess the risk factors associated with hallux reulceration. Sixty patients with diabetic neuropathy and a history of previous ulcer were consecutively included. Sociodemographic factors and comorbidities plus the biomechanical and radiographic factors were obtained. Follow-up on participants was conducted every month, and they wore offloading therapeutic footwear and custom-made insoles. Hallux reulceration during the follow-up period was assessed as the main outcome measure in the study. Results Patients were followed up during 29 (14.2-64.4) months. Twenty-nine patients (52%) developed a new ulceration: 9 patients (31%) in the hallux and 20 (69%) in other locations. Functional hallux limitus (p = 0.005, 95% CI (2.097–73.128), HR 12.384) and increased body mass index (p = 0.044, 95% CI (1.003-1.272), HR 1.129) were associated with the hallux ulceration-free survival time in the multivariate Cox model. Conclusions Obesity and the presence of functional hallux limitus increase the probability of developing hallux reulceration in patients with diabetic neuropathy and a history of ulcers.
Highlights
The lifetime incidence of foot ulcers in people with diabetes has been recently estimated to be between 19% and 34% [1]
Preulcerative lesion, peripheral arterial disease, foot deformity, and increased plantar pressure have been identified as the main risk factors for diabetic foot ulcer (DFU) [4, 5]
Sixty individuals were consecutively evaluated according to the following criteria: aged over 18 years, diagnosed with type 1 or type 2 diabetes mellitus (DM) according to the criteria of the American Diabetes Association, presence of peripheral neuropathy, presence of a first event of a recently healed ulcer, and location of the ulcer on the forefoot
Summary
The lifetime incidence of foot ulcers in people with diabetes has been recently estimated to be between 19% and 34% [1]. At least 85% of lower-extremity amputations are preceded by a diabetic foot ulcer (DFU), which severely increases the economic costs of health care and decreases life expectancy [2]. The primary prevention of DFU becomes critical, since death in the first year following diagnosis of the first DFU has been reported in as many as 12% of patients [3]. Preulcerative lesion, peripheral arterial disease, foot deformity, and increased plantar pressure have been identified as the main risk factors for DFU [4, 5]. Forty percent of patients will have a recurrence within 1 year following healing of the ulcer. The precipitating factors that initially led to the ulcer are generally not resolved after healing [1]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have